Your browser doesn't support javascript.
loading
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium.
van Erp, T G M; Hibar, D P; Rasmussen, J M; Glahn, D C; Pearlson, G D; Andreassen, O A; Agartz, I; Westlye, L T; Haukvik, U K; Dale, A M; Melle, I; Hartberg, C B; Gruber, O; Kraemer, B; Zilles, D; Donohoe, G; Kelly, S; McDonald, C; Morris, D W; Cannon, D M; Corvin, A; Machielsen, M W J; Koenders, L; de Haan, L; Veltman, D J; Satterthwaite, T D; Wolf, D H; Gur, R C; Gur, R E; Potkin, S G; Mathalon, D H; Mueller, B A; Preda, A; Macciardi, F; Ehrlich, S; Walton, E; Hass, J; Calhoun, V D; Bockholt, H J; Sponheim, S R; Shoemaker, J M; van Haren, N E M; Hulshoff Pol, H E; Pol, H E H; Ophoff, R A; Kahn, R S; Roiz-Santiañez, R; Crespo-Facorro, B; Wang, L; Alpert, K I.
Afiliação
  • van Erp TG; Department of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.
  • Hibar DP; Imaging Genetics Center, University of Southern California, Los Angeles, CA, USA.
  • Rasmussen JM; Department of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.
  • Glahn DC; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Pearlson GD; Olin Neuropsychiatric Research Center, Institute of Living, Hartford, CT, USA.
  • Andreassen OA; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Agartz I; Olin Neuropsychiatric Research Center, Institute of Living, Hartford, CT, USA.
  • Westlye LT; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Haukvik UK; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Dale AM; Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Melle I; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Hartberg CB; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Gruber O; Department of Psychology, University of Oslo, Oslo, Norway.
  • Kraemer B; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Zilles D; MMIL, Department of Radiology, University of California, San Diego, CA, USA.
  • Donohoe G; Department of Cognitive Science, Neurosciences and Psychiatry, University of California, San Diego, CA, USA.
  • Kelly S; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • McDonald C; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Morris DW; Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Cannon DM; Department of Psychiatry, University Medical Center Göttingen, Göttingen, Germany.
  • Corvin A; Department of Psychiatry, University Medical Center Göttingen, Göttingen, Germany.
  • Machielsen MW; Department of Psychiatry, University Medical Center Göttingen, Göttingen, Germany.
  • Koenders L; Center for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry and Psychotherapy, Georg August University, Göttingen, Germany.
  • de Haan L; Cognitive Genetics and Therapy Group, School of Psychology, National University of Ireland, Galway, Ireland.
  • Veltman DJ; Neuropsychiatric Genetics research group, Department of Psychiatry and Trinity College Institute of Psychiatry, Trinity College, Dublin, Ireland.
  • Satterthwaite TD; Imaging Genetics Center, University of Southern California, Los Angeles, CA, USA.
  • Wolf DH; Neuropsychiatric Genetics research group, Department of Psychiatry and Trinity College Institute of Psychiatry, Trinity College, Dublin, Ireland.
  • Gur RC; Clinical Neuroimaging Laboratory, College of Medicine, Nursing and Health Sciences, National University of Ireland, Galway, Ireland.
  • Gur RE; Cognitive Genetics and Therapy Group, School of Psychology, National University of Ireland, Galway, Ireland.
  • Potkin SG; Neuropsychiatric Genetics research group, Department of Psychiatry and Trinity College Institute of Psychiatry, Trinity College, Dublin, Ireland.
  • Mathalon DH; Clinical Neuroimaging Laboratory, College of Medicine, Nursing and Health Sciences, National University of Ireland, Galway, Ireland.
  • Mueller BA; Neuropsychiatric Genetics research group, Department of Psychiatry and Trinity College Institute of Psychiatry, Trinity College, Dublin, Ireland.
  • Preda A; Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Macciardi F; Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Ehrlich S; Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Walton E; University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Hass J; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Calhoun VD; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Bockholt HJ; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Sponheim SR; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Shoemaker JM; Department of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.
  • van Haren NE; Department of Psychiatry, University of California, San Francisco, CA, USA.
  • Hulshoff Pol HE; San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
  • Pol HE; Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA.
  • Ophoff RA; Department of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.
  • Kahn RS; Department of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.
  • Roiz-Santiañez R; Translational Developmental Neuroscience Section, Department of Child and Adolescent Psychiatry, Technische Universität, Dresden, Germany.
  • Crespo-Facorro B; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Wang L; MGH/MIT/HMS Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, USA.
  • Alpert KI; Translational Developmental Neuroscience Section, Department of Child and Adolescent Psychiatry, Technische Universität, Dresden, Germany.
Mol Psychiatry ; 21(4): 547-53, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26033243
ABSTRACT
The profile of brain structural abnormalities in schizophrenia is still not fully understood, despite decades of research using brain scans. To validate a prospective meta-analysis approach to analyzing multicenter neuroimaging data, we analyzed brain MRI scans from 2028 schizophrenia patients and 2540 healthy controls, assessed with standardized methods at 15 centers worldwide. We identified subcortical brain volumes that differentiated patients from controls, and ranked them according to their effect sizes. Compared with healthy controls, patients with schizophrenia had smaller hippocampus (Cohen's d=-0.46), amygdala (d=-0.31), thalamus (d=-0.31), accumbens (d=-0.25) and intracranial volumes (d=-0.12), as well as larger pallidum (d=0.21) and lateral ventricle volumes (d=0.37). Putamen and pallidum volume augmentations were positively associated with duration of illness and hippocampal deficits scaled with the proportion of unmedicated patients. Worldwide cooperative analyses of brain imaging data support a profile of subcortical abnormalities in schizophrenia, which is consistent with that based on traditional meta-analytic approaches. This first ENIGMA Schizophrenia Working Group study validates that collaborative data analyses can readily be used across brain phenotypes and disorders and encourages analysis and data sharing efforts to further our understanding of severe mental illness.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Encéfalo Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Psychiatry Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Encéfalo Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Psychiatry Ano de publicação: 2016 Tipo de documento: Article